Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

10
Number of overlapping holdings
33.3%
% of MEDX's 30 holdings also in PPH
41.7%
% of PPH's 27 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in MEDX |
Weight in PPH |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 17.1% | 11.7% | 11.7% | |
ABBVIE INC | 9.4% | 6.2% | 6.2% | |
NOVARTIS AG-ADR | 7.2% | 5.5% | 5.5% | |
JOHNSON & JOHNSON | 5.4% | 6.7% | 5.4% | |
ASTRAZENECA PLC-SPONS ADR | 5.8% | 4.9% | 4.9% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to PPH
AMGEN INC | 6.7% | |
ELI LILLY & CO | 5.5% | |
ALNYLAM PHARMACEUTICALS INC | 4.8% | |
ALKERMES PLC | 4.3% | |
ABBVIE INC | 3.2% | |
CRISPR THERAPEUTICS AG | 2.9% | |
REGENERON PHARMACEUTICALS | 2.8% | |
BIOGEN IDEC INC | 2.5% | |
IONIS PHARMACEUTICALS, INC. | 2.4% | |
BRISTOL-MYERS SQUIBB CO | 2.0% |
MEDX Underweight Relative to PPH
CENCORA INC | -5.6% | |
MCKESSON CORP | -5.4% | |
SANOFI-AVENTIS-ADR | -5.0% | |
NOVO-NORDISK A/S-SPONS ADR | -4.8% | |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -4.6% | |
ZOETIS INC | -4.6% | |
TEVA PHARMACEUTICAL-SP ADR | -4.1% | |
VIATRIS, INC. | -2.0% | |
GLAXOSMITHKLINE PLC-SPON ADR | -1.7% | |
JAZZ PHARMACEUTICALS PLC | -1.7% |